BDO 1
Selected indexed studies
- Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. (Neurosci Biobehav Rev, 2015) [PMID:25843781]
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). (Autophagy, 2016) [PMID:26799652]
- Combining CRISPR and CRISPRi Systems for Metabolic Engineering of E. coli and 1,4-BDO Biosynthesis. (ACS Synth Biol, 2017) [PMID:28854333]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Developed and emerging 1,4-butanediol commercial production strategies: forecasting the current status and future possibility. (2024) pubmed
- Production of 1,4-Butanediol from Succinic Acid Using Escherichia Coli Whole-Cell Catalysis. (2024) pubmed
- Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use. (2015) pubmed
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). (2016) pubmed
- Combining CRISPR and CRISPRi Systems for Metabolic Engineering of E. coli and 1,4-BDO Biosynthesis. (2017) pubmed
- Advances in biosynthesis and downstream processing of diols. (2024) pubmed
- Synthetic redesign of Corynebacterium glutamicum for 1,4-butanediol production via L-glutamate-derived CoA-independent pathway. (2025) pubmed
- Enhanced 1,4-Butanediol de Novo Synthesis in Yarrowia lipolytica by Incorporating Dynamic Regulation of Thiamine. (2025) pubmed
- Metabolic Engineering of Escherichia coli for De Novo Production of 1,2-Butanediol. (2024) pubmed
- Achievements and Perspectives in 1,4-Butanediol Production from Engineered Microorganisms. (2021) pubmed